Alkermes Investigational Site

Indianapolis, Indiana

We've found

1 trials

at this facility

A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Indianapolis, IN

Use our guide to learn which trials are right for you!